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INTRODUCTION:  Hemangiopericytoma  (HPC)  is a rare mesenchymal  tumor  derived  from  capillary  and
postcapillary  pericytes  that  often  has  an  indolent  course  and  occasionally  presents  with  abdominal
metastasis.
PRESENTATION  OF  CASE:  Twenty-three  years  after  the  initial  resection  of  an  intracranial  HPC  located  in
the right  frontoparietal  region  and  left lateral  ventricle,  a 63-year-old  man  experienced  dull  abdominal
pain  and  early  satiety  and  had a  palpable  epigastric  mass.  Computed  tomography  indicated  a suspected
metastasis  of HPC  to the  left upper  abdomen.  On  laparoscopic  exploration,  the  tumor  was  found  in  the
falciform  ligament  and  was excised  laparoscopically  per request  of  the  patient.  He  had  a  fast  recovery
and  experienced  good  relief  of  his  pain  and  satiety.  The  patient  had  2  additional  metastases  at  his  12-
month  follow-up,  both  in  the  right  retroperitoneum,  and he again  underwent  laparoscopic  resection.  At
his  next  annual  follow-up,  new  metastases  were  identiﬁed  in his  liver,  small-bowel  mesentery,  and  peri-
toneal  surface,  prompting  a trial of systemic  chemotherapy.  Because  of  progress  of  a left lower  abdominal
preperitoneal  metastasis  on follow-up  at 3 years,  the patient  underwent  a further  successful  laparoscopic
exploration.  Postoperatively,  systemic  chemotherapy  was  maintained.
DISCUSSION:  We  report  the recurrent  laparoscopic  resection  of  peritoneal  metastases  of  primary  intracra-
nial  HPC  with  good  symptom  control  and  fast recovery.  Both  the  patient  and  the  referring  physician
requested  a minimally  invasive  surgical  approach.
CONCLUSION:  Laparoscopic  resection  is  a feasible  treatment  strategy  for intraperitoneal  metastases  and
is effective  in  symptom  palliation.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Originally described in 1942 by Stout and Murray [1], heman-
iopericytoma (HPC) is a rare mesenchymal tumor derived from
ericytes, the cells of capillary walls and postcapillary venule walls
2]. This tumor type accounts for less than 1% of all sarcomas and
an occur at any location in the body, including intra-abdominally
3]. Although most HPC has an indolent course usually, poorly dif-
erentiated HPC frequently can have an aggressive tumor biology
nd a poor prognosis [4–6]. Intracranial HPC is rare, estimated to
ccount for 0.4% of primary intracranial neoplasms; the ideal treat-
ent regimen has yet to be delineated [1,6,7]. Gross total resection
Abbreviations: CT, computed tomography; HPC, hemangiopericytoma; WHO,
orld Health Organization.
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210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/4.0/).is the only therapy with a proven survival beneﬁt for central ner-
vous system HPC [8–10], though adjuvant radiation therapy leads
to longer tumor-free survival [6,11] and multimodal therapy has
become the standard of care [12].
Recurrence rates have been reported as high as 42–90%, with
time of recurrence at a median of 5 years after initial resection but
as late as 27 years [6,9,13]. Extracranial metastases occur in 20% of
cases, through both hematogenous and lymphatic routes [6,7,14].
Commonly reported areas of extracranial metastases include bone,
liver, lung, and skin [1,6,14].
We report the case of a patient with primary intracranial HPC
that metastasized to the peritoneal cavity.
2. Presentation of caseA laparoscopic resection found metastatic HPC in a 63-year-old
man. He had received a diagnosis of primary intracranial HPC at age
40 years. Initially, 2 lesions were found: a 3-cm mass in the base
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Computed tomographic scan showing large metastasis in the falciform liga-
ment. The arrow indicates the metastasis.
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Fig. 2. Computed tomographic scan showing metastases in the (A) right retrorenal
retroperitoneum and (B) hepatic ﬂexure attachments of the right colon. The arrow
indicates the retrorenal metastasis.f the right frontoparietal region and a 1-cm mass in the left lat-
ral ventricle. Pathologic analysis indicated the lesions were World
ealth Organization (WHO) grade II. Fourteen years after his ini-
ial surgery, the patient had a new lesion in the right frontal lobe,
hich was resected and identiﬁed as a WHO  grade III recurrent
PC. After this second operation, he underwent adjuvant external
eam radiation therapy.
Five years later, a pathologic fracture of his right femur occurred,
nd imaging showed a likely metastatic HPC. The HPC was  treated
ith surgical resection and ﬁxation, and pathologic evaluation con-
rmed WHO  grade III metastatic HPC. In addition, a metastatic
ork-up consisting of computed tomography (CT) of the chest,
bdomen, and pelvis showed 2 additional intra-abdominal lesions:
 6-cm lesion in the epigastric area and a 2-cm lesion in the right
etroperitoneum. At that time, the patient was asymptomatic, and
hus, the lesions were observed.
After 4 more years and at 23 years after his initial tumor
esection, the patient presented with dull abdominal pain, early
atiety, and a palpable epigastric mass. CT showed a consider-
ble increase in size of the epigastric lesion to 10 cm in maximum
iameter (Fig. 1). He was taken to the operating room for
aparoscopic resection. The tumor was identiﬁed in the peri-
oneal space attached to the falciform ligament. This mass was
emoved successfully with ultrasonic dissection. The patient did
ell and was discharged 2 days after the operation without
omplication.
At his 12-month follow-up, 2 additional asymptomatic lesions
ere noted on CT. The right retroperitoneal mass had substan-
ially increased in size since previous scans, measuring 10 cm in
aximum diameter, and the patient had a new 1-cm metastasis
n the retroperitoneal attachments of the hepatic ﬂexure of the
ight colon (Fig. 2). He again underwent a laparoscopic resection
f his tumor recurrences. The smaller mass was removed easily.
he right colon then was mobilized, allowing visualization and sub-
equent dissection of the right retrorenal mass with an ultrasonic
issection (Fig. 3). The patient tolerated the procedure well andwas discharged 3 days after the operation. However, subsequent
annual follow-up showed new metastases to the liver, small-bowel
mesentery, and several peritoneal nodules on CT (Fig. 4). Given
his advanced intra-abdominal disease, the patient underwent a
trial of chemotherapy. This treatment was  partially successful at
slowing his disease; however, 3 years later, left lower abdomi-
nal preperitoneal metastases became progressively symptomatic,
and the patient underwent further laparoscopic exploration and
resection. In this interval, he also had pathologic fractures in the
right femur and left humerus secondary to metastatic disease,
which were treated by curettage and ﬁxation, as well as an L1
vertebral metastasis that was  treated with radioablation and verte-
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Fig. 3. Laparoscopic resection using ultrasonic dissection. (A) Tumor is visible in
tissue. (B) Tumor after it was  dissected free.
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troplasty. His treatment continued as varying regimens of systemic
hemotherapy, including temozolomide, bevacizumab, pazopanib,
emcitabine, and doxorubicin in the intervals.
. Discussion
Our case report conﬁrms the potentially aggressive nature
nd metastatic potential of malignant HPC. Late recurrences have
een reported in the literature as long as 27 years after the ini-
ial surgical resection [2,13]. Little is known about the course
f HPC metastatic disease. The current best treatment is sur-
ical resection of all known disease; an optimal management
trategy for recurrent and metastatic disease has yet to be fully
lucidated [1,12].
The patient in this case presented with local recurrence
nd delayed bony metastasis, a commonly reported devel-
pment in HPC. However, he subsequently had additional
etastases that presented in a delayed manner and occurred in
he peritoneal cavity and retroperitoneum. His peritoneal and
etroperitoneal disease was treated using a laparoscopic tech-
ique in accordance with the patient’s request, and the beneﬁts of
aparoscopic resection can be seen in his uneventful postoperative
ourse.
Though initially resected to negative margins, the patient’s
etastatic disease eventually progressed beyond what could be
reated surgically.Fig. 4. Computed tomographic scans (A and B) show metastases to small-bowel
mesentery.
4. Conclusion
Laparoscopic resection of symptomatic HPC metastases is fea-
sible and effective in relieving symptoms. Repeat resections can be
safely performed laparoscopically.
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